Bloomberg Anywhere Login


Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.


Financial Products

Enterprise Products


Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000


Industry Products

Media Services

Follow Us

Last CNY29.50 CNY
Change Today +1.33 / 4.72%
Volume 24.1M
002038 On Other Exchanges
As of 3:00 AM 08/28/15 All times are local (Market data is delayed by at least 15 minutes).

beijing sl pharmaceutical -a (002038) Snapshot

Previous Close
Day High
Day Low
52 Week High
06/3/15 - CNY50.59
52 Week Low
08/26/15 - CNY25.55
Market Cap
Average Volume 10 Days
Shares Outstanding
Dividend Yield
Current Stock Chart for BEIJING SL PHARMACEUTICAL -A (002038)

Related News

No related news articles were found.

beijing sl pharmaceutical -a (002038) Related Businessweek News

No Related Businessweek News Found

beijing sl pharmaceutical -a (002038) Details

Beijing SL Pharmaceutical Co., Ltd., a biotechnology-pharmaceutical company, develops and markets gene engineering drugs for human health. Its principal products include Li Sheng Su, a recombinant human granulocyte colony-stimulating factor for injection; Mai Ge Er, a recombinant human interleukin-11 for injection; and Xin Ji Er, a recombinant human 125Ala interleukin-2 for injection. The company also offers Fu Ji Fu, a lyophilized recombinant human basic fibroblast growth factor for external use. In addition, it provides products for oncology, organ transplantation, cardiovascular, wound management, liver diseases, as well as APIs. The company was formerly known as Beijing BaiLuyuan Bio-Pharmaceutical Co., Ltd and changed its name to Beijing SL Pharmaceutical Co., Ltd. in 1998. The company was founded in 1994 and is based in Beijing, the People’s Republic of China.

Founded in 1994

beijing sl pharmaceutical -a (002038) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

beijing sl pharmaceutical -a (002038) Key Developments

Beijing SL Pharmaceutical Co., Ltd. to Report First Half, 2015 Results on Aug 24, 2015

Beijing SL Pharmaceutical Co., Ltd. announced that they will report first half, 2015 results on Aug 24, 2015

Beijing SL Pharmaceutical Co., Ltd. Announces Final Distribution Plan for 2014, Payable on July 15, 2015

Beijing SL Pharmaceutical Co., Ltd. announced that 2014 final distribution plan to be implemented (A shares) of cash dividend per 10 shares (tax included) of CNY 3.00000000. Net amount after tax per 10 shares was CNY 2.20000000. Record date is July 14, 2015. Ex-date is July 15, 2015. The dividend is payable on July 15, 2015.

Beijing Sl Pharmaceutical Co., Ltd. Announces Board Changes; Approves Cash Dividend for the Year 2014

Beijing SL Pharmaceutical Co., Ltd. at its AGM held on May 28, 2015, approved cash dividend of CNY 3.00000000 per 10 shares (tax included) for the year 2014. The company approved the election of Xu Mingbo, Chen Yulin, Liang Shujie, Wang Wenxin as non-independent director. The company approved the election of Su Zhiguo and Wei Suyan as independent director and the election of Zhang Chunlei and Qi Yanming as supervisor.


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
002038:CH CNY29.50 CNY +1.33

002038 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 002038.
View Industry Companies

Industry Analysis


Industry Average

Valuation 002038 Industry Range
Price/Earnings 27.3x
Price/Sales 16.3x
Price/Book 5.6x
Price/Cash Flow 27.3x
TEV/Sales 14.9x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BEIJING SL PHARMACEUTICAL -A, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at